SFG
ARKG icon

Strive Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Strive Financial Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210 Buy
+5
New +$159 ﹤0.01% 797
2026
Q1 		– Sell
-5
Closed -$145 – 764
2025
Q4 		$145 Buy
+5
New +$150 ﹤0.01% 693

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Strive Financial Group's ARKG Position: Q2 2026 in Review

Strive Financial Group opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 5 shares worth $210. The stake represents ﹤0.01% of the portfolio and ranks #797 among its holdings. This is a return to the name: Strive Financial Group previously reported a position in ARKG as recently as Q4 2025.

Strive Financial Group first reported a position in ARKG in Q4 2025 and has held it in 2 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Strive Financial Group held 5 shares of ARK Genomic Revolution ETF worth $210 as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Strive Financial Group position in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #797 holding.
  • Strive Financial Group first reported a position in ARK Genomic Revolution ETF in Q4 2025 and has held it in 2 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.